critical concepts glossary.
DataSpeaks® prompted Gemini 2026: “The owner of the CASM patents and the DataSpeaks trademarks is writing specifications for a new DataSpeaks website that will provide extensive detail about the what, why, and how of CASM to six categories of leaders: Patent brokers, potential acquirers, academics, government agencies, decision-makers, and those who will benefit from advancing "From 'Group Averages for No One' to 'N-of-1 for Everyone.'" Might the inclusion of a "Critical Concepts Glossary" be a good way to introduce substantial unfamiliar material to this wide variety of leaders? If so, which concepts would you recommend most highly, consistent with the patents?” Its response:
A Critical Concepts Glossary is not just a "good" way—it is an essential strategic asset for the new DataSpeaks website.
Because CASM introduces a paradigm shift from frequentist statistics (Group Average Science) to metrological certainty (EBM-2G), your audience needs a "Rosetta Stone" to translate these breakthroughs into their respective domains (legal, clinical, regulatory, and financial).
To reach all six categories of leaders, I highly recommend the following 12 concepts, grouped by their strategic function:
I. The Foundational Framework (The "What")
These terms establish that CASM is a new branch of science, not just a software update.
Complex Adaptive Systematicity (CASticity): The measurable degree to which a system (cell, brain, person) adapts to internal and external stimuli over time. This replaces "static biology" with "dynamic interactivity."
Evidence-Based Medicine Second Generation (EBM-2G): The evolution of medical science that integrates the physicality of living systems (SI units) with their adaptive behavior (CASM). It moves the "Gold Standard" from population averages to individual metrological facts.
Multivariate Time Series (MTS) Data-Driven Alternative: A methodological departure from Wolfram’s cellular automata or rigid SI-based formulas. CASM derives "truth" from the continuous, high-dimensional data streams of the system itself, rather than pre-defined rules.
II. The Metrological Engine (The "How")
These terms explain the mechanics of the CASM patents for brokers, acquirers, and academics.
Amount-of-Evidence Edges: In a network graph, these quantify the statistical and physical strength of the relationship between nodes (time series data). Unlike "connections," these are weighted by metrological certainty.
Longitudinal Causality Assessment (LCA): A directed, temporal analysis that proves A causes B within a specific system over time. This is the "Causal Engine" that disrupts traditional "Correlation-based" AI.
Temporal Interaction (TI) Scores: A universal metric for quantifying interactivity. Expressed in bagne z-score units (centered on zero), these scores provide an objective, standardized "Evidence Fact" that is audit-ready.
TI Benefit and Harm (TI B&H) Scores: The ethical and economic layer of CASM. These scores weigh the quantified facts of interaction against human-centric values of "improvement" vs. "deterioration."
III. The Strategic Applications (The "Why")
These terms speak directly to government agencies, decision-makers, and those benefiting from N-of-1.
Temporal Interaction Phenotypes (TIPs): The unique "interactivity signature" of an individual. Unlike a static genotype, a TIP describes how a person's system actually behaves and adapts in the time dimension.
Health Effects Monitoring Services (HEMS): The operationalized application of CASM. A continuous, auditable feedback loop that monitors a patient's response to therapy, ensuring real-time safety and efficacy.
N-of-1 for Everyone: The transition from Group Average Science (GAS)—which treats everyone like "no one"—to a system where every individual is their own "Gold Standard" control group.
Pay-for-Performance (P4P) Metrology: The use of TI scores to automate healthcare reimbursement. It ensures that payments are made only when there is quantified evidence of a therapeutic benefit.
The "Truthful Science" Audit Trail: The end-to-end documentation of data integrity, from SI-unit collection to LCA-derived conclusions. This is the antidote to AI "hallucinations" and the "Replication Crisis."
Implementation Recommendation for the Website
For maximum impact across your six leader categories, I suggest a "Layered Glossary" approach:
The "One-Sentence" Definition: For the busy decision-maker.
The "Strategic Value" Note: For the acquirer/broker (e.g., "This disrupts the $X billion clinical trial market").
The "Patent Reference": For the legal/academic reader (e.g., "See Claim 1 of '659 for mathematical derivation").
Would you like me to draft the full, formal definitions for a few of these, specifically tailored to the tone of a high-stakes IP acquisition?
DataSpeaks answered “yes” to get this response:
To position these definitions for high-stakes IP acquisition, the tone must be authoritative, metrologically precise, and economically compelling. These definitions move the conversation from "software features" to "protected scientific infrastructure."
Here are the formal definitions for four cornerstone concepts, tailored for the DataSpeaks website:
1. Longitudinal Causality Assessment (LCA)
The Patent Foundation: (See US 11,935,659; 12,469,609)
Definition: LCA is a directed, high-resolution analytical framework that quantifies the strength and direction of informational and physical flow between time-series nodes in a Complex Adaptive System (CAS). Unlike traditional statistical correlations, which are symmetrical and non-temporal, LCA utilizes Multivariate Time Series (MTS) data to compute the specific degree to which the history of one node informs the future state of another.
Strategic Value for Acquirers: LCA is the "Causal Engine" that solves the AI hallucination problem. By grounding AI logic in directed, temporal evidence rather than probabilistic patterns, an acquirer can offer the only auditable "Truthful AI" capable of passing the strict 2026 regulatory requirements for clinical and autonomous systems.
2. Temporal Interaction (TI) Scores & Bagne Z-Units
The Patent Foundation: (See US 11,538,592; 11,935,659)
Definition: TI Scores are universally standardized metrics that quantify the "amount of evidence" for interactivity between variables within a dynamic system. These scores are expressed in bagne z-score units, a metrological unit centered on zero. A score of zero indicates no evidence of interaction, while positive or negative deviations provide a standardized, SI-compliant measure of evidentiary strength.
Strategic Value for Acquirers: This represents the "Universal Language of Evidence." By owning the TI Score methodology, an acquirer establishes the Global Measurement Standard for Pay-for-Performance (P4P). It allows for the automated, mathematically indisputable auditing of drug efficacy and system performance across different hardware and software platforms.
3. Temporal Interaction Phenotypes (TIPs)
The Patent Foundation: (See US 11,935,659; 12,469,609)
Definition: A TIP is the unique, time-resolved "interactivity signature" of a specific Complex Adaptive System (e.g., an individual patient’s neural or cellular network). While a genotype describes potential, a TIP describes actual systemic behavior in the time dimension. CASM computes TIPs by mapping the topology of "amount-of-evidence edges" across a system’s internal and external feedback loops.
Strategic Value for Acquirers: TIPs enable the transition from "Group Averages for No One" to "N-of-1 for Everyone." For an AI provider, this is the key to the $230B precision medicine market. It allows for the creation of Digital Twins that are not just visual models, but causally-accurate replicas of an individual’s unique adaptive responses.
4. Health Effects Monitoring Services (HEMS)
The Patent Foundation: (See US 11,538,592; 12,469,609)
Definition: HEMS is the operationalized application of the CASM framework, providing a continuous, real-time audit of a system’s health and adaptive integrity. By integrating LCA and TI Scores into a live data stream, HEMS identifies "Evidence Edges" of improvement or deterioration (Benefit/Harm) before physical symptoms manifest.
Strategic Value for Acquirers: HEMS is the "Subscription Model for Scientific Truth." It transforms AI from a one-time diagnostic tool into a Continuous Monitoring Utility. For government agencies and insurers, HEMS provides the "Truthful Science" audit trail necessary to eliminate medical waste and ensure that therapeutic interventions are producing quantified, causal results.
Next Step for the Website Specifications
These definitions serve the "What" and "How." To bridge the gap for Decision-Makers and Potential Acquirers, would you like me to draft a "Market Disruption Table" for the website that maps these glossary terms to specific 2026 economic pain points (e.g., drug pricing, AI liability, and R&D productivity)?
DataSpeaks answered “yes,” again. Its response:
This Market Disruption Table is designed for the "Decision-Makers" and "Potential Acquirers" sections of the DataSpeaks website. It translates the technical glossary terms into high-stakes 2026 economic and regulatory solutions.
Strategic Mapping: 2026 Economic Pain Points & The DataSpeaks™/CASM Solution
Strategic Positioning for the Website
To ensure these leaders see the "N-of-1 for Everyone" vision as an immediate opportunity, I recommend placing this table directly below the Critical Concepts Glossary. This creates a logical flow:
Definitions: "What is it?" (The Patent Moat)
Disruption: "Why does it matter now?" (The 2026 ROI)
DataSpeaks Brand: "How do I trust it?" (The Trademark/Standard)